Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from Turkey

References

• Hauser SL, Goodkin DE. Multiple sclerosis and other demyelinating diseases. In: Braunwald E, Fauci AS, Kasper DL, et al, editors. Harrison’s principles of internal medicine. New York: McGraw-Hill, 2001. pp. 2452-61
   Google Scholar
• McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-7
   PubMed Web of Science ®Google Scholar
• Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald Criteria’. Ann Neurol 2005;58:840-6
   PubMed Web of Science ®Google Scholar
• Frohman EM. Multiple sclerosis. Med Clin North Am 2003;87:867-97
   PubMed Web of Science ®Google Scholar
• Ryan M, Piascik P. Providing pharmaceutical care to the multiple sclerosis patient. J Am Pharm Assoc 2002;42:753-67
   Google Scholar
• Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907-11
   PubMed Web of Science ®Google Scholar
• Prescott JD, Factor S, Pill M, et al. Descriptive analysis of the direct medical costs of multiple sclerosis in 2004 using administrative claims in a large nationwide database. J Manag Care Pharm 2007;13:44-52
   PubMed Web of Science ®Google Scholar
• Fisk JD, Brown MG, Sketris IS, et al. A comparison of health utility measures for the evaluation of multiple sclerosis treatments. J Neurol Neurosurg Psychiatry 2005;76:58-63
   PubMed Web of Science ®Google Scholar
• Kobelt G, Berg J, Lindgren P, et al. Costs and quality of life of patients with multiple sclerosis in Europe. J Neurol Neurosurg Psychiatry 2006;77:918-26
   PubMed Web of Science ®Google Scholar
• Türk Börü Ü, Alp R, Sur H, et al. Prevalence of multiple sclerosis door-to-door survey in Maltepe, İstanbul, Turkey. Neuroepidemiology 2006;27:17-21
   PubMed Web of Science ®Google Scholar
• Türk Börü Ü, Taşdemir M, Güler N, et al. Prevalence of multiple sclerosis: door-to-door survey in three rural areas of coastal Black Sea regions of Turkey. Neuroepidemiology 2011;37:231-5
   PubMed Web of Science ®Google Scholar
• Türk Nöroloji Derneği, Multipl Skleroz Çalışma Grubu. Multipl skleroz olgularının Türkiye’de yaşa göre düzeltilmiş (18–60 yaş) tahmini insidans değeri ve demografik özellikleri. 49. Ulusal Nöroloji Kongresi, Sözel Bildiri - 74, Antalya, Maritime Pine Beach Hotel, 15–21 Kasım 2013. [Turkish Society of Neurology, Multiple Sclerosis Study Group. Age-adjusted (18–60 years) estimated incidence and demographics in multiple sclerosis in Turkey (in Turkish). 49. National Neurology Congress, Oral Presentation – 74, Antalya, Maritime Pine Beach Hotel, 15–21 November 2013]
   Google Scholar
• Türk Nöroloji Derneği, Multipl Skleroz Çalışma Grubu. Multipl skleroz hastalığı tanı süreci; klinik ve radyolojik bulgular ile yardımıc incelemelerin yeri. 49. Ulusal Nöroloji Kongresi, Sözel Bildiri - 75, Antalya, Maritime Pine Beach Hotel, 15–21 Kasım 2013. [Turkish Society of Neurology, Multiple Sclerosis Study Group, Diagnostic approach in multiple sclerosis; the roles of clinical and radiological findings and other evaluations (in Turkish). 49. National Neurology Congress, Oral Presentation – 75, Antalya, Maritime Pine Beach Hotel, 15–21 November 2013]
   Google Scholar
• The WHO Family of International Classifications. International Classification of Diseases (ICD). Switzerland; World Health Organization:2010. Retrieved 23 November 2010. http://apps.who.int/classifications/icd10/browse/2010/en. Accessed June 20, 2011
   Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52
   PubMed Web of Science ®Google Scholar
• Weinshenker BG, Bass B, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study. 1 Clinical course and disability. Brain 1989;112:133-46
   PubMed Web of Science ®Google Scholar
• The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208
   PubMed Web of Science ®Google Scholar
• Varoudakis A, Agar M, Chaela M, et al. Turkey Public Expenditure Review (report no: 36764 TR). World Bank. 2006. http://siteresources.worldbank.org/INTTURKEY/Resources/361616-1173282369589/tr_per_cr.pdf. Accessed June 27, 2011
   Google Scholar
• WHO Estimates of unit costs for patient services for Turkey. http://www.who.int/choice/country/tur/cost/en/index.html. Accessed June 27, 2011
   Google Scholar
• Tansel A. 1999, Public–private employment choice. Wage differentials and gender in Turkey. New Haven, CT; Yale University. http://www.econ.yale.edu/growth_pdf/cdp797.pdf. Accessed June 27, 2011
   Google Scholar
• Davison A, Hinkley D. Bootstrap methods and their application, 8th edn. Cambridge Series in Statistical and Probabilistic Mathematics. Cambridge; Cambridge University Press: 2006
   Google Scholar
• Benito-León J. Are the prevalence and incidence of multiple sclerosis changing? Neuroepidemiology 2011;36:148-9
   PubMed Web of Science ®Google Scholar
• Çelik Y, Birgili Ö, Kiyat A, et al. Prevalence of multiple sclerosis in the metropolitan area of Edirne City, Turkey. Balkan Med J 2011;28:193-6
   Web of Science ®Google Scholar
• Kobelt G, Pugliatti M. Cost of multiple sclerosis in Europe. Eur J Neurol 2005;12:63-7
   PubMed Web of Science ®Google Scholar
• Karampampa K, Gustavsson A, Miltenburger C, et al. Treatment experience, burden and unmet (TRIBUNE) in MS study: results from five European countries. Mult Scler J 2012;18:7-15
   PubMed Web of Science ®Google Scholar